Trial | NCT04505228  Report issue

Title

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia
The Personalized Chinese Herb Formulas Are Evaluated for Their Effectiveness to Relieve Symptoms in Hypertensive Bradyarrhythmia

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    72
72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.
To test the effect of Chinese herb against the hypertensive heart disease, we designed this randomized controlled clinical trial. 72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. 2 weeks after treatment, all the symptoms were graded again.
Study Started
Jan 20
2020
Primary Completion
Mar 20
2020
Study Completion
Jun 20
2020
Last Update
Aug 10
2020

Drug Safflower (Carthamus Tinctorius) IgG4 | Serum | Allergy

The designed Chinese herb formulas

  • Other names: Xuefuzhuyu

Drug Atropine Sulfate

The basic treatment for heart disease

Research group Experimental

The patients receiving Atropine and the extra Chinese herb formulas treatment

Control group Active Comparator

The patients receiving the basic treatment of atropine

Criteria 

Inclusion Criteria:

* Clinical diagnosis of hypertensive bradyarhhythmia

Exclusion Criteria:

With other elementary diseases
With pregnant
With receiving other treatment within past half year from the beginning of trial.
No Results Posted